On the scales: Social justice and pluralism in reproductive tourism
By Gina Maranto, Biopolitical Times guest contributor
| 02. 01. 2011
The term “reproductive tourism” first surfaced in Canada in the late 1980s as that country carried out an exhaustive survey of public opinion under the Royal Commission headed by Dr. Patricia Baird. The coinage was used to refer to the prospect that unless the government passed comprehensive national laws, women and couples unable to obtain treatments in their own province would seek them out in another. By 1999, Canadians were using it to talk about women who, when refused high risk procedures there, went to the U.S. instead. Today, borders are being crossed throughout the EU, where member states have quite different codes, among different U.S. states, and internationally.
In some quarters, a concerted effort has been made to rename the practice, giving it a less negative spin as “
cross-border [or transborder] reproductive care.” Some have also hyperbolically framed those who travel outside their own countries for reproductive services as victims of repressive legal systems, “
reproductive exiles” who take on added risks by traveling abroad, because if procedures go awry, they are unlikely to have ready...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...